Arrowstreet Capital’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $762M | Sell |
2,580,320
-494,453
| -16% | -$147M | 0.41% | 42 |
|
|
2025
Q4 | $840M | Buy |
3,074,773
+208,318
| +7% | +$56.6M | 0.49% | 40 |
|
|
2025
Q3 | $774M | Sell |
2,866,455
-966,635
| -25% | -$263M | 0.49% | 43 |
|
|
2025
Q2 | $1.06B | Buy |
3,833,090
+238,522
| +7% | +$64.9M | 0.75% | 20 |
|
|
2025
Q1 | $954M | Buy |
3,594,568
+178,207
| +5% | +$44M | 0.77% | 18 |
|
|
2024
Q4 | $793M | Buy |
3,416,361
+819,158
| +32% | +$188M | 0.64% | 21 |
|
|
2024
Q3 | $573M | Buy |
2,597,203
+418,691
| +19% | +$86.6M | 0.49% | 44 |
|
|
2024
Q2 | $428M | Buy |
2,178,512
+371,943
| +21% | +$76.8M | 0.38% | 64 |
|
|
2024
Q1 | $389M | Buy |
1,806,569
+586,472
| +48% | +$123M | 0.36% | 65 |
|
|
2023
Q4 | $257M | Buy |
1,220,097
+756,633
| +163% | +$161M | 0.27% | 81 |
|
|
2023
Q3 | $92.8M | Buy |
463,464
+385,454
| +494% | +$76.6M | 0.11% | 165 |
|
|
2023
Q2 | $14.5M | Buy |
78,010
+48,307
| +163% | +$8.93M | 0.02% | 442 |
|
|
2023
Q1 | $5.69M | Buy |
29,703
+20,850
| +236% | +$3.77M | 0.01% | 667 |
|
|
2022
Q4 | $1.49M | Buy |
8,853
+6,821
| +336% | +$1.19M | ﹤0.01% | 942 |
|
|
2022
Q3 | $360K | Sell |
2,032
-12,311
| -86% | -$2.43M | ﹤0.01% | 1143 |
|
|
2022
Q2 | $2.94M | Sell |
14,343
-530,605
| -97% | -$112M | ﹤0.01% | 699 |
|
|
2022
Q1 | $130M | Sell |
544,948
-203,770
| -27% | -$47.9M | 0.16% | 149 |
|
|
2021
Q4 | $171M | Sell |
748,718
-66,667
| -8% | -$14.7M | 0.21% | 119 |
|
|
2021
Q3 | $158M | Buy |
815,385
+607,799
| +293% | +$123M | 0.2% | 116 |
|
|
2021
Q2 | $44.1M | Buy |
207,586
+169,986
| +452% | +$35.9M | 0.05% | 355 |
|
|
2021
Q1 | $7.68M | Buy |
37,600
+30,255
| +412% | +$5.96M | 0.01% | 985 |
|
|
2020
Q4 | $1.34M | Sell |
7,345
-438,666
| -98% | -$74.6M | ﹤0.01% | 1736 |
|
|
2020
Q3 | $74.6M | Buy |
446,011
+97,277
| +28% | +$16.4M | 0.12% | 163 |
|
|
2020
Q2 | $56.7M | Buy |
348,734
+255,968
| +276% | +$45.9M | 0.1% | 177 |
|
|
2020
Q1 | $16M | Buy |
92,766
+87,892
| +1,803% | +$17.5M | 0.05% | 353 |
|
|
2019
Q4 | $978K | Buy |
4,874
+774
| +19% | +$159K | ﹤0.01% | 1342 |
|
|
2019
Q3 | $866K | Buy |
+4,100
| New | +$857K | ﹤0.01% | 1196 |
|
|
2019
Q2 | – | Sell |
-44,863
| Closed | -$7.38M | – | 1424 |
|
|
2019
Q1 | $7.38M | Buy |
44,863
+27,797
| +163% | +$4.91M | 0.02% | 656 |
|
|
2018
Q4 | $3.21M | Sell |
17,066
-542,265
| -97% | -$100M | 0.01% | 680 |
|
|
2018
Q3 | $95.2M | Sell |
559,331
-928,703
| -62% | -$156M | 0.22% | 112 |
|
|
2018
Q2 | $244M | Sell |
1,488,034
-1,018,311
| -41% | -$166M | 0.6% | 43 |
|
|
2018
Q1 | $405M | Buy |
2,506,345
+305,012
| +14% | +$48.6M | 0.93% | 22 |
|
|
2017
Q4 | $322M | Buy |
2,201,333
+764,129
| +53% | +$109M | 0.77% | 28 |
|
|
2017
Q3 | $195M | Buy |
1,437,204
+987,604
| +220% | +$125M | 0.52% | 56 |
|
|
2017
Q2 | $56.3M | Buy |
449,600
+444,500
| +8,716% | +$53.2M | 0.17% | 147 |
|
|
2017
Q1 | $606K | Buy |
+5,100
| New | +$613K | ﹤0.01% | 1065 |
|
|
2016
Q4 | – | Sell |
-141,958
| Closed | -$14.8M | – | 1777 |
|
|
2016
Q3 | $14.8M | Sell |
141,958
-19,073
| -12% | -$1.99M | 0.05% | 354 |
|
|
2016
Q2 | $15.7M | Sell |
161,031
-563,637
| -78% | -$53.3M | 0.05% | 324 |
|
|
2016
Q1 | $69.6M | Buy |
724,668
+152,212
| +27% | +$13.8M | 0.29% | 80 |
|
|
2015
Q4 | $51.9M | Sell |
572,456
-463,516
| -45% | -$43.6M | 0.24% | 90 |
|
|
2015
Q3 | $96.1M | Buy |
1,035,972
+99,800
| +11% | +$9.49M | 0.46% | 44 |
|
|
2015
Q2 | $87.1M | Buy |
936,172
+11,609
| +1% | +$1.08M | 0.49% | 54 |
|
|
2015
Q1 | $87.6M | Buy |
924,563
+250,920
| +37% | +$23.2M | 0.54% | 48 |
|
|
2014
Q4 | $59.7M | Buy |
673,643
+299,738
| +80% | +$25.4M | 0.34% | 70 |
|
|
2014
Q3 | $29.9M | Buy |
+373,905
| New | +$28.2M | 0.16% | 148 |
|
|
2014
Q2 | – | Sell |
-7,034
| Closed | -$521K | – | 1009 |
|
|
2014
Q1 | $521K | Sell |
7,034
-583,347
| -99% | -$44M | ﹤0.01% | 956 |
|
|
2013
Q4 | $46.3M | Buy |
+590,381
| New | +$46.2M | 0.25% | 101 |
|
Other funds holding CME
VCM
VPM
Arrowstreet Capital's CME Position: Q1 2026 in Review
Arrowstreet Capital reduced its CME Group (CME) stake by 16% in Q1 2026, selling an estimated $147M and leaving 2,580,320 shares worth $762M. The position accounts for 0.41% of the portfolio, ranked #42.
Arrowstreet Capital first reported a position in CME in Q4 2013 and has held it in 47 quarters since. The position peaked at $1.06B in Q2 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Arrowstreet Capital held 2,580,320 shares of CME Group worth $762M as of Q1 2026.
- Arrowstreet Capital sold 494,453 CME Group shares in Q1 2026, an estimated $147M.
- CME Group made up 0.41% of Arrowstreet Capital's portfolio in Q1 2026, its #42 holding.
- Arrowstreet Capital first reported a position in CME Group in Q4 2013 and has held it in 47 quarters since.
- Arrowstreet Capital's CME Group position peaked at $1.06B in Q2 2025.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.